Model-based control of neuromuscular block using mivacurium: Design and clinical verification

European Journal of Anaesthesiology

Volumn 23, Issue 8, 2006, Pages 691-699

  Schumacher, P M ^a   Stadler, K S ^b   Wirz, R ^a   Leibundgut, D ^a   Pfister, C A ^a   Zbinden, A M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

Anaesthesia general; Computer simulation; Electromyography; Neuromuscular blockade, monitoring, automation, closed loop control; Neuromuscular blocking agents, mivacurium

Indexed keywords

CLOSED LOOP CONTROL; FENTANYL; MIVACURIUM; OPIATE; PROPOFOL; REMIFENTANIL; SHORT ACTING DRUG; UNCLASSIFIED DRUG;

ADULT; ANESTHESIA INDUCTION; ARTICLE; AUTOMATION; CLINICAL ARTICLE; COMPUTER SIMULATION; DRUG DOSE REGIMEN; DRUG INFUSION; DRUG USE; ELECTRODE; ELECTROMYOGRAPHY; ENDOTRACHEAL INTUBATION; FEMALE; GENERAL ANESTHESIA; HUMAN; INFORMATION PROCESSING; INFUSION PUMP; MALE; MATHEMATICAL MODEL; NEUROMUSCULAR BLOCKING; PATIENT MONITORING; SENSOR;

ADULT; ANESTHESIOLOGY; DRUG DELIVERY SYSTEMS; ELECTROMYOGRAPHY; EQUIPMENT DESIGN; FEMALE; FENTANYL; HUMANS; ISOQUINOLINES; MALE; MIDDLE AGED; MODELS, THEORETICAL; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PIPERIDINES; PROPOFOL; REPRODUCIBILITY OF RESULTS; SAFETY; TIME FACTORS; TREATMENT OUTCOME;

EID: 33745684468     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021506000524     Document Type: Article

References (26)

1. Eriksson LI, Sato M, Severinghaus JW. Effect of a vecuronium-induced partial neuromuscular block on hypoxic ventilatory response. Anesthesiology 1993; 78: 693-699.
2. Viby-Mogensen J. Postoperative residual curarization and evidence-based anaesthesia. Br J Anaesth 2000; 84: 301-303.
3. Olkkola KT, Schwilden H, Apffelstaedt C. Model-based adaptive closed-loop feedback control of atracurium-induced neuromuscular blockade. Acta Anaesthesiol Scand 1991; 35: 420-423.
4. Olkkola KT, Schwilden H. Adaptive closed-loop feedback control of vecuronium-induced neuromuscular relaxation. Eur J Anaesthesiol 1991; 8: 7-12.
5. Meretoja OA, Olkkola KT. Pharmacodynamics of mivacurium in children, using a computer-controlled infusion. Br J Anaesth 1993; 71: 232-237.
6. Geldner G, Schwarz U, Ruoff M et al. Development of a new closed-loop system for controlling mivacurium-induced neuromuscular blockade. Anaesthesist 1999; 48: 157-162. [German]
7. Kansanaho M, Olkkola KT. Performance assessment of an adaptive model-based feedback controller: comparison between atracurium, mivacurium, rocuronium and vecuronium. Int J Clin Monit Comput 1996; 13: 217-224.
8. Caldwell JE. New skeletal muscle relaxants. Int Anesthesiol Clin 1995; 33(1): 39-60 (Review).
9. Viby-Mogensen J. Neuromuscular monitoring. In: Miller RD, ed. Anesthesia. Philadelphia: Churchill-Livingstone Inc, 2000: 1351-1366.
10. Viby-Mogensen J, Engbaek J, Eriksson LI et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996; 40: 59-74.
11. Savarese JJ, Ali HH, Basta SJ et al. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug. Anesthesiology 1988; 68: 723-732.
12. Stadler KS, Leibundgut D, Schumacher PM et al. Modelling and closed-loop control of skeletal muscle relaxation during general anaesthesia using mivacurium. European Control Conference ECC 2003.
13. Lien CA, Schmith VD, Embree PB, Belmont MR, Wargin WA, Savarese JJ. The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/ barbiturate anesthesia. Anesthesiology 1994; 80(6): 1296-1302.
14. Cook DR, Freemann JA, Lai AA et al. Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal failure. BJA 1992; 69: 580-585.
15. Schumacher PM, Stadler KS, Zbinden AM. Performance assessment of feedback control systems for drug delivery in anesthesia. World Congress on Medical Physics and Biomedical Engineering, Sydney 2003.
16. Varvel JR, Donoho DL, Shafer SL. Measuring the predictive performance of computer-controlled infusion pumps. J Pharmacokinet Biopharm 1992; 20: 63-94.
17. Ostergaard D, Viby-Mogensen J, Pedersen NA, Holm H, Skovgaard LT. Pharmacokinetics and pharmacodynamics of mivacurium in young adult and elderly patients. Acta Anaesthesiol Scand 2002; 46(6): 684-691.
18. Ali HH, Savarese JJ, Embree PB et al. Clinical pharmacology of mivacurium chloride (BW B109OU) infusion: comparison with vecuronium and atracurium. Br J Anaesth 1988; 61: 541-546.
19. De Mey JC, Fonck K, Mareels K, Rolly G. The influence of isoflurane on a continuous infusion of mivacurium. Anaesthesia 1995; 50: 947-949.
20. Powers DM, Brandom BW, Cook DR et al. Mivacurium infusion during nitrous oxide-isoflurane anesthesia: a comparison with nitrous oxide-opioid anesthesia. J Clin Anesth 1992; 4: 123-126.
21. Ezzine S, Donati F, Varin F. Mivacurium arteriovenous gradient during steady state infusion in anesthetized patients. Anesthesiology 2002; 97: 622-629.
22. Maddineni VR, Mirakhur RK, McCoy EP, Sharpe TD. Neuromuscular and haemodynamic effects of mivacurium in elderly and young adult patients. Br J Anaesth 1994; 73: 608-612.
23. Brandom BW, Woelfel SK, Cook DR, Weber S, Powers DM, Weakly JN. Comparison of mivacurium and suxamethonium administered by bolus and infusion. Br J Anaesth 1989; 62: 488-493.
24. Pellissier D, Bruder N, Mokart D et al. Continuous administration of mivacurium for short procedures. Delayed onset and recovery from neuromuscular blockade. Ann Fr Anesth Reanim 1995; 14: 467-471.
25. Viby-Mogensen J, Ostergaard D, Donati F et al. Pharmacokinetic studies of neuromuscular blocking agents: good clinical research practice (GCRP). Acta Anaesthesiol Scand 2000; 44: 1169-1190.
26. Arbous MS, Meursing AE, van Kleef JW et al. Impact of anesthesia management characteristics on severe morbidity and mortality. Anesthesiology 2005; 102 (2): 257-268; quiz 491-492.